Get Ready to Geek Out: ACELYRIN INC. Invites You to a Virtual Investor Event for an Exclusive Sneak Peek at Exciting Phase 2 Data and Phase 3 Program Plans for Subcutaneous Lonigutamab!

Welcome to the Future of Medicine Los Angeles, Jan. 02, 2025 – In a groundbreaking announcement, Acelyrin, Inc. has revealed plans to showcase updated Phase 2 data for their latest medicine, lonigutamab, during a virtual investor event on Monday, January 6, 2025. This event is set to shed light on the potential of lonigutamab in…

Read More

Breaking News: S&P Dow Jones Indices Releases New Guidelines for S&P Composite 1500 Market Cap

S&P Dow Jones Indices Updates Market Capitalization Eligibility Criteria Introduction On January 2, 2025, S&P Dow Jones Indices (“S&P DJI”) announced a significant update to the market capitalization eligibility criteria for companies being added to the S&P Composite 1500 Indices. These changes, set to take effect immediately, will impact the composition of the S&P 500,…

Read More

Zscaler: A Must-Have Investment for the Future

Zscaler Reports Impressive Q1 FY25 Earnings Key Highlights Zscaler’s Q1 FY25 earnings report has stunned investors and analysts alike, showcasing a remarkable 26% year-over-year revenue growth and an astounding 48% year-over-year earnings growth. This stellar performance has exceeded expectations and has led to a positive revision in the company’s FY25 guidance, indicating a promising future…

Read More

Uncovering the Truth: Investigating Securities Fraud Class Action Against Capri Holdings Limited (CPRI) – A Call to Investors from the Law Offices of Howard G. Smith

The Impact of the Capri Holdings Limited Class Action Lawsuit on Investors Overview The Law Offices of Howard G. Smith has announced that a class action lawsuit has been filed on behalf of investors who purchased Capri Holdings Limited (“Capri” or the “Company”) (NYSE: CPRI) securities or sold puts between August 10, 2023 and October…

Read More